A new Commonwealth Fund study finds that, following implementation of the Affordable Care Act, premiums for employer-sponsored insurance in 31 states grew more slowly than in previous years.
A new Commonwealth Fund study finds that, following implementation of the Affordable Care Act (ACA), premiums for employer-sponsored insurance in 31 states grew more slowly than in previous years.
But more costs were also shifted to employees in the form of premiums and deductibles, and by 2013, premium costs ate up more than 20% of income in 37 states, according to the study.
Premium increases from 2010 to 2013 grew three times faster than income, while per-person deductibles at least doubled in all but six states and the District of Columbia.
p
Noting that premiums in the ACA’s federal marketplace were also slower than expected, the study says the main reason for the slowdown in premium growth is a decline in healthcare spending since 2009.
Based on an analysis of claims data, the study found that families and employees had used fewer services between 2009 and 2014, including hospital care and elective surgery.
Quality initiates implemented as a part of the ACA, including alterative models of care delivery and efforts to reduce waste and duplication, might also be contributing to the slowdown in premium growth, notes the study.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
2 Commerce Drive
Cranbury, NJ 08512